Filippo Marino, Francesco Rossi, & Emilio Sacco. (2023). Mirabegron, a First-in-class Non-antimuscarinic Drug for the Overactive Bladder. Novel Research Aspects in Medicine and Medical Science Vol. 8, 48–67. https://doi.org/10.9734/bpi/nramms/v8/9482F